Topic Editors

Dr. Elisa Karkle
Grain Science and Industry, Kansas State University, Manhattan, KS 66506, USA
Department of Food, Nutrition, Dietetics and Health, Kansas State University, Manhattan, KS 66506, USA
Dr. Rosana Colussi
Center of Chemical, Pharmaceutical and Food Sciences, Pelotas Federal University, Pelotas 96010-610, RS, Brazil
Dr. Ling Sun
School of Food and Biological Engineering, Jiangsu University, Zhenjiang 212013, China

Cereal Nutrients, Bioactive Compounds, and Their Health Impact

Abstract submission deadline
31 January 2027
Manuscript submission deadline
31 March 2027
Viewed by
1615

Topic Information

Dear Colleagues,

Cereals (e.g., rice, wheat, barley, and maize) have been staple foods for millennia, providing essential macro- and micronutrients and a diverse range of bioactive compounds. Their macronutrient profile includes digestible and nondigestible carbohydrates, proteins, and lipids varying in amount and structure depending on the grain and process history. Cereals are important sources of B-vitamins, iron, zinc, and magnesium, with processing also playing a key role in their bioaccessibility. Beyond nutrients, cereals contain various bioactive compounds that have antioxidant and anti-inflammatory effects. Research groups around the world are exploring additional compounds, health benefits, and responses to processing. This topic aims to concentrate a portion of the current research on increased discoverability and impact.   

Dr. Elisa Karkle
Dr. Valentina Trinetta
Dr. Rosana Colussi
Dr. Ling Sun
Topic Editors

Keywords

  • cereal grains
  • dietary fiber
  • micronutrients
  • polyphenols
  • antioxidants
  • metabolic health
  • grain processing

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Agriculture
agriculture
3.6 6.3 2011 18.8 Days CHF 2600 Submit
Antioxidants
antioxidants
6.6 12.4 2012 18.7 Days CHF 2900 Submit
Crops
crops
1.9 2.4 2021 22.4 Days CHF 1200 Submit
Foods
foods
5.1 8.7 2012 15 Days CHF 2900 Submit
Nutraceuticals
nutraceuticals
- - 2021 21.1 Days CHF 1200 Submit
Nutrients
nutrients
5.0 9.1 2009 15 Days CHF 2900 Submit

Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

  1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
  2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
  3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
  4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
  5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (1 paper)

Order results
Result details
Journals
Select all
Export citation of selected articles as:
34 pages, 2323 KB  
Review
Natural Products in the Metabolic and Endocrine Modulation of Polycystic Ovary Syndrome: Current Perspectives
by Siqi Liu, Rui Wang, Weili Yu, Chuanjing Shi, Xi Wang, Aifen Liu and Lei Zhang
Nutrients 2026, 18(6), 964; https://doi.org/10.3390/nu18060964 - 18 Mar 2026
Cited by 1 | Viewed by 1044
Abstract
Polycystic ovary syndrome (PCOS) is a prevalent endocrine and metabolic disorder, primarily characterized by reproductive dysfunction, insulin resistance (IR), and long-term metabolic complications. Current first-line pharmacological treatments, including oral contraceptives, anti-androgens, and insulin sensitizers, can alleviate clinical symptoms but often fail to fully [...] Read more.
Polycystic ovary syndrome (PCOS) is a prevalent endocrine and metabolic disorder, primarily characterized by reproductive dysfunction, insulin resistance (IR), and long-term metabolic complications. Current first-line pharmacological treatments, including oral contraceptives, anti-androgens, and insulin sensitizers, can alleviate clinical symptoms but often fail to fully address the underlying pathophysiology, and their long-term use is frequently limited by adverse effects. Natural products, owing to their multi-target regulatory properties and favorable safety profiles, have emerged a promising adjuvant therapeutic strategy. This review systematically summarizes how natural products exert beneficial effects through mechanisms such as improving metabolic homeostasis by enhancing insulin sensitivity and mitigating oxidative stress and chronic inflammation; restoring endocrine balance by modulating the hypothalamic–pituitary–gonadal axis to reduce hyperandrogenemia and promote ovulation; and utilizing emerging pathways including regulating gut microbiota homeostasis and epigenetic modifications as a novel avenue for PCOS drug development. Preclinical and clinical evidence collectively indicates that these agents hold significant translational potential to ameliorate metabolic disturbances and improve reproductive outcomes, providing a scientific foundation for future integrated intervention strategies in PCOS. Full article
Show Figures

Figure 1

Back to TopTop